Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Feasibility and Effect of Resistance Training and Protein Supplementation in Patients With Advanced Gastroesophageal Cancer
ClinicalTrials.gov study NCT05650827. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT06879041. IPD Sharing: YES. Countries: 3. Publications: 0.
Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial
ClinicalTrials.gov study NCT06363734. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT04768608. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT07381582. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
ClinicalTrials.gov study NCT06353386. IPD Sharing: YES. Countries: 20. Publications: 0.
Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients
ClinicalTrials.gov study NCT01634061. IPD Sharing: Not stated. Countries: 6. Publications: 0.
A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.
ClinicalTrials.gov study NCT07354022. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT07042802. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT01494012. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea
ClinicalTrials.gov study NCT01137136. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT05547061. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spre
ClinicalTrials.gov study NCT06470243. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
ClinicalTrials.gov study NCT06425133. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT07287150. IPD Sharing: YES. Countries: 3. Publications: 0.
Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer
ClinicalTrials.gov study NCT00080743. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers
ClinicalTrials.gov study NCT03924245. IPD Sharing: NO. Countries: 1. Publications: 0.
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT06517719. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)
ClinicalTrials.gov study NCT01595087. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing
ClinicalTrials.gov study NCT02353715. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.